搜索公司,投资者……

Synergenics

synergenics.net

阶段

格兰特 |活着

总了

100美元

最后提出了

100美元 | 14年前

关于Synergenics

Synergenics公司收到了SBIR第一阶段资助项目的标题为:Bead-Based Label-free DNA微阵列读出。他们的项目探索小说为DNA微阵列检测系统,这是玻璃芯片包含不同的分子硬币大小的遗传物质。DNA微阵列已经彻底改变了基础研究和工业药物发现,但历来难以在临床诊断中使用。DNA微阵列数据通常是昂贵的,需要漫长的等待时间,因为需要化学标签样品材料。相比之下,Synamem公司(Synergenics, LLC)正在开发一种新的DNA微阵列读出使用micron-size珠粒子完全消除了需要标签的样本材料,使过程相当低成本、更快速。这个SBIR项目将地址如下:1)DNA微阵列label-free读出将优化;2)这个读出将测试在各种领域的潜在的诊断应用DNA微阵列的癌症;3)这个label-free读出的兼容性和商业化微阵列将评估。更广泛的影响这一研究DNA微数组技术的发展有可能被用于诊断更具成本效益和效率的基础上。成功的商业化和采用Synamem label-free微阵列的系统将大大简化测量基因表达的过程中,检测基因单核苷酸多态性与变异,和许多其他潜在的诊断应用的DNA微阵列。 Indeed, it will enable faster diagnostic results in the clinic, closer to the patient, as it may eliminate the need for sending out samples for lengthy processing in centralized hospital laboratories. This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5).

总部的位置

欧文斯街1700号

旧金山,加州,94158年,

美国

(415)554 - 8170

缺失:Synergenics产品演示和案例研究

促进你的产品提供技术买家。

达到1000年代的买家使用CB的见解来确定供应商,演示产品,德赢体育vwin官方网站做出购买决定。

缺失:Synergenics产品&微分器

不要让你的产品被跳过。买家使用我们的供应商排名名单公司和驱动(rfp)请求建议。

Synergenics专利

1 Synergenics提起了专利。

专利图

申请日

授予日期

标题

相关的话题

状态

12/12/2017

集群的区别,G蛋白耦合的受体,单位的信息,单克隆抗体,热休克蛋白质

应用程序

申请日

12/12/2017

授予日期

标题

相关的话题

集群的区别,G蛋白耦合的受体,单位的信息,单克隆抗体,热休克蛋白质

状态

应用程序

最新的Synergenics新闻

Ventria Bioscience制药医疗交易和联盟概要报告更新27092018价格250美元

2018年10月30日

子公司总结Ventria Bioscience Ventria Synergenics有限责任公司是一家生物制药公司开发重组药物和其他生物技术产品。公司的expresstec plantbased重组蛋白重组蛋白的生产制造技术,小肽,multisubunit分子,单克隆抗体,酶融合蛋白,用于医药和生物技术。其治疗管道包括产品和新的人类治疗性疫苗控制人畜共患疾病,解决这个问题通过产生高度纯生物活性的重组治疗性蛋白质效率高。Ventria VEN150管道产品包括药品,VEN120。该公司还生产前置产品合同。Ventria总部设在结城,堪萨斯州,美国。Ventria Bioscience制药医疗交易和联盟为您提供全面的数据和趋势分析公司并购的MAs,伙伴关系和融资。报告提供详细信息的并购,股票/债券发行、私募股权、风险融资和合作公司交易记录的一个五年计划。报告提出了详细的比较数据,交易数量和他们的价值分为交易类型,界别分组和地区。GlobalData这份报告中给出的数据来自内部专有的制药eTrack交易数据库,和小学和中学的研究。 Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Synergenics常见问题(FAQ)

  • Synergenics总部在哪里?

    Synergenics总部位于欧文斯街1700号,旧金山。

  • Synergenics的最新一轮融资是什么?

    格兰特Synergenics的最新一轮融资。

  • Synergenics筹集了多少钱?

    Synergenics筹集了总计100美元。

  • Synergenics的投资者是谁?

    投资者Synergenics包括国家科学基金会。

发现正确的解决方案为您的团队

CB见解德赢体育vwin官方网站科技市场情报平台分析数百万数据点在供应商、产品、合作关系,专利来帮助您的团队发现他们的下一个技术解决方案。

请求一个演示

CBI的网站通常使用一些饼干,使更好的相互作用我们的网站和服务。使用这些饼干,这可能是存储在你的设备上,允许我们的改进和定制你的经历。你可以阅读更多关于你的饼干的选择在我们的隐私政策在这里。继续使用这个你同意这些选择。

Baidu
map